Clinical trials recruiting in Plauen, Germany

Phase breakdown

Conditions recruiting in Plauen, Germany

Recruiting trials in Plauen, Germany

• A Comparison Study of Persistence of UPadacitinib vs. TNF-inhibitoRs In a German Real-world SettING
  NCT06712628 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• A Non-interventional Study for Kisqali (Ribociclib) in Combination With an Aromatase Inhibitor for Adjuvant Treatment in Patients With HR+/HER2- Early Breast Cancer at High Risk of Recurrence
  NCT06830720 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)
• Combination of Abemaciclib and Endocrine Therapy in Hormone Receptor Positive HER2 Negative Locally Advanced or Metastatic Breast Cancer With Focus on Digital Side Effect Management
  NCT05362760 · Phase: Phase 4 · Ages: 18 Years and older · Sex: Female
• The Helios Heart Registry: A Standardized Registry for Patients With Specific Cardiac Diseases
  NCT04844944 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Plauen, Germany?

4 recruiting trials have at least one study site in Plauen, Germany.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.